Evidence map›Paper›PMID 42232188›Full record

ArticleFrontiers in pharmacology2026

Exploring the probiotic landscape in understanding postbiotics from indigenous bacteria isolated from the stool samples of a tribal population at Mulluvadi village, Tamil Nadu, India.

G R Shree Kumari, Mohanasrinivasan Vaithilingam

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

G R Shree KumariSchool of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Mohanasrinivasan VaithilingamSchool of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Urbanisation has been associated with a decline in the diversity of the gut microbiome that could potentially limit access to functionally robust probiotic strains. In contrast, traditional tribal populations represent underexplored reservoirs of diverse microbiota with unique metabolic capabilities. In this study, isolated and functionally characterised culturable probiotic bacteria from the gut microbiomes of individuals from the Mulluvadi tribal community (Tamil Nadu, India), with a focus on their inferred postbiotic-producing potential. Methods: A total of 112 microbial isolates were obtained from the stool samples of 25 healthy individuals, from which 13 representative bacterial strains were shortlisted by sequential screening based on phenotypic and functional criteria. These isolates were evaluated for tolerance to gastrointestinal stress conditions (pH, bile salts, NaCl, and temperature), cell surface hydrophobicity, auto-aggregation, safety attributes, and functional properties, including antibacterial activity, exopolysaccharide production, protease activity, biofilm formation, and short-chain fatty acid (SCFA) production. Results: The 13 isolates, mainly comprising Conclusion: Probiotic isolates from the gut microbiomes of a tribal population show remarkable postbiotic-producing capacity and potential functional relevance. These strains are promising candidates for further investigations toward the development of postbiotic-based functional formulations; however, their efficacies must be first established in animal and clinical trials and validated through additional

Indexed as

gut healthpostbioticsprobioticsStool sampletribal gut microbiome

Identifiers

PMID42232188
PMCPMC13222833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.